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Abstract
Background: In a population-based sample of school-age children, we investigated
factors associated with rhinitis, and differences between allergic and nonallergic
rhinitis. Amongst children with asthma, we explored the association between rhi-
nitis and asthma severity.
Methods: Children participating in a birth cohort study (n = 906) were reviewed
at age 8 years. Asthma was defined as at least two of the following three features:
physician-diagnosed asthma, currently using asthma medication and current
wheeze. We measured lung function (plethysmography and spirometry) and air-
way hyper-reactivity (AHR; methacholine challenge).
Results: In the analysis adjusted for the presence of asthma, children with rhinitis
had significantly higher AHR (P = 0.001). Maternal smoking and absence of breast-
feeding were stronger predictors of nonallergic rhinitis, whereas current wheeze and
eczema were stronger predictors of allergic rhinitis. Amongst asthmatics (n = 159),
when compared to 76 children without rhinitis, those with rhinitis (n = 83) were 2.89-
fold (95% CI 1.41–5.91) more likely to experience frequent attacks of wheezing, 3.44-
fold (1.19–9.94) more likely to experience severe attacks of wheezing limiting speech,
10.14-fold (1.27–81.21) more likely to have frequent visits to their doctor because of
asthma and nine-fold (1.11–72.83) more likely to miss school. Reported use of intra-
nasal corticosteroids resulted in a numerically small, but consistent reduction in risk,
rendering the associations between rhinitis and asthma severity nonsignificant.
Conclusion: We observed differences in risk factors and severity between allergic
and nonallergic rhinitis. In children with asthma, rhinitis had adverse impact on
asthma severity. The use of intranasal corticosteroids resulted in a small, but con-
sistent reduction in the risk.
Although rhinitis is one of the most common chronic dis-
eases in childhood (1, 2), only a minority of symptomatic
children have appropriate diagnosis (3, 4). The burden of the
disease to individual patients and the society is often underes-
timated, and there is a general paucity of data on the risk
factors and phenotypes of rhinitis in childhood (1). Numer-
ous epidemiological studies have demonstrated a link
between rhinitis and asthma (1), with rhinitis often preceding
asthma development (5). There is evidence to suggest that
amongst adult asthmatics, those with comorbid rhinosinusitis
have poorer quality of life (6), and chronic rhinitis may
be an important comorbidity of severe asthma (7). A cross-
sectional study amongst children and adolescents with
moderate/severe asthma treated with inhaled corticosteroids
(ICS) suggested that concurrent allergic rhinitis may be a risk
factor for the use of emergency care services (8). A recent
cross-sectional survey amongst 203 children with asthma has
reported that allergic rhinitis in this patient group is common
and has an adverse impact on asthma control (9). However,
most previous studies on the impact of rhinitis on childhood
asthma severity have been carried out in selected populations
of asthmatics attending secondary/tertiary care specialist
services (8, 9), and the effect at a population level is
unknown.
We aimed to investigate the risk factors for rhinitis in a
population-based sample of school-age children participating
in an unselected birth cohort and whether there are
differences in risk factors between allergic and nonallergic
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rhinitis. Amongst children with asthma, we investigated the
association between rhinitis and asthma severity.
Methods
Study design
Manchester Asthma and Allergy Study is a population-based
birth cohort (10). Subjects were recruited antenatally and fol-
lowed prospectively. The study was approved by the local




Participants attended follow-up at age 8 years. Validated
ISAAC questionnaire (11) was interviewer-administered to
collect information on parentally reported symptoms, doctor
diagnoses and environmental exposures. We performed skin
prick tests to common inhalant allergens (mite, cat, dog,
grass and tree pollen [Bayer, Elkhart, USA]).
Medical records data
We extracted all data from electronic and paper-based pri-
mary care medical records, including prescriptions of ICS
and intranasal corticosteroids (INCS) between January 2006
and February 2008 (median age 10 years).
Lung function, airway hyper-reactivity and airway
inflammation
We measured specific airway resistance (sRaw) using plethys-
mography (12). We used spirometry to measure FEV1
(expressed as % predicted) and FVC (13). Airway hyper-
reactivity (AHR) was assessed using methacholine challenge
(five-step protocol with quadrupling doses of methacholine)
(14). We calculated methacholine dose–response slope
(MDRS) to include all evaluable data as a continuous vari-
able (15). Fractional exhaled nitric oxide (FeNO) was mea-
sured as an indicator of airway inflammation (16).
Definition of variables
Atopy
Mean wheal diameter ≥3 mm than the negative control to at
least one allergen.
Current rhinitis
Positive response to the question ‘In the past 12 months, has
your child ever had a problem with sneezing, or a runny
nose, or a blocked nose when he/she did not have a cold or
the flu?’ We designated current rhinitis in the presence of
atopy as allergic rhinitis, whilst nonallergic rhinitis was
defined as current rhinitis in the absence of atopy.
Current wheeze
Positive response to the question ‘Has your child had wheez-
ing or whistling in the chest in the last 12 months?’
Current asthma
At least two of the following three features: (i) current
wheeze, (ii) current use of asthma medication and (iii) physi-
cian-diagnosed asthma ever.
Wheeze phenotypes
Using prospectively collected data, we defined wheeze pheno-
types as no wheezing, transient-early wheezing, intermittent
wheezing, late-onset wheezing and persistent wheezing (17).
Current maternal smoking
Positive response to the question ‘Does the child’s mother
smoke at present?’
Markers of asthma severity
Number of wheeze attacks
Parentally reported number of attacks of wheezing their child
had in the past 12 months. Troublesome asthma was defined
as four or more attacks.
Nocturnal awakenings
Ascertained by the question ‘In the past 12 months, how
often, on average has your child’s sleep been disturbed due
to wheezing?’ We defined troublesome asthma as one or
more nights with disturbed sleep per week.
Wheeze limiting speech
Positive answer to the question ‘In the past 12 months, has
wheezing been severe enough to limit your child’s speech to
only one or two words at a time between breaths?’
Visits to family doctor for wheeze/asthma
Troublesome asthma was defined as four or more visits in
the past 12 months.
School days missed due to wheezing/asthma
Parentally reported number of school days the child missed
in the past 12 months. We defined troublesome asthma as 6
or more days.
Statistical analysis
Univariate and multivariate analyses were carried out using
logistic regression (SPSS 20.0, Chicago, IN, USA). Analysis
was carried out assuming that covariate data were missing
completely at random. The effect size was measured using
odds ratios (OR) and 95% confidence interval (CI). All mod-
els were adjusted for gender.
Results
Participant flow and demographic data
Of 1184 children born into the study, 133 were allocated to
an intervention group and excluded from this analysis (18).
Questionnaire data were available for 906 children, of whom
815 underwent skin testing, 724 lung function testing, 628
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methacholine challenges and 205 FeNO measurements
(Fig. 1). Current rhinitis was present in 260 of 906 (29%)
children, of whom 229 had skin tests data (140 were desig-
nated as having allergic, and 89 as nonallergic rhinitis). Of
the 905 (18%) participants, 159 had asthma; 259 of 815
(31.7%) were atopic. Figure S1 shows the prevalence and
overlap of comorbid current rhinitis, asthma and eczema.
Factors associated with rhinitis
Results of the univariate analysis are shown in Table S1. We
performed multiple logistic regression analysis including all
factors significantly associated with current rhinitis in the
univariate analysis. Wheeze in the first year of life (OR 1.53,
95% CI 1.04–2.24, P = 0.03), current eczema (1.90, 1.24–
2.91, P = 0.003), and sensitization to grass (3.87, 2.26–6.64,
P < 0.001) and cat (2.05, 1.09–3.86, P = 0.03) remained inde-
pendent associates of rhinitis. We then ascertained the differ-
ences in risk factors between allergic and nonallergic rhinitis
(Table 1). Maternal smoking and having never been breast-
fed were significantly stronger predictors of nonallergic rhini-
tis, whereas current wheeze and eczema were significantly
stronger predictors of allergic rhinitis. Using interference with
daily activities as a marker of severity, allergic rhinitis
appeared to be more severe than nonallergic rhinitis
(Table 1). As expected, allergic rhinitis was more likely to
have a seasonal pattern.
Both wheeze and asthma were strongly associated with
rhinitis, but different associations were observed for differ-
ent wheeze phenotypes. We observed strong associations
with persistent and late-onset wheeze, but there was no
association between rhinitis and transient-early wheezing;
these associations appeared stronger for allergic than
nonallergic rhinitis (Table S2).
In the analysis adjusted for the presence of asthma, chil-
dren with rhinitis had significantly higher AHR (MDRS;
mean difference [95% CI], 0.85 [1.34 – ()0.36],
P = 0.001) and FeNO (mean difference [95% CI], 0.37 [0.21–
0.53], P < 0.001); these associations were significantly stron-
ger for allergic than nonallergic rhinitis (Table S3). Amongst
atopic children, there was no difference in FeNO between
those with and without rhinitis (mean difference [95% CI],
0.23 [0.09 to 0.57], P = 0.17). We found no difference in
lung function (sRaw, FEV1 and FEV1/FVC) between chil-
dren with and without rhinitis.
Rhinitis and asthma severity
Amongst 159 children with asthma, 83 had contemporaneous
rhinitis. There was no significant difference in AHR between
children with rhinitis compared to those without; similarly,
we observed no difference in lung function (Table S4). An
apparent difference in FeNO between asthmatic children with
and without rhinitis was no longer significant after adjust-
ment for atopy (P = 0.16).
In contrast, we observed marked differences between asth-
matic children with and without rhinitis in the frequency of
wheeze attacks, wheeze limiting speech, unscheduled visits to
family doctor because of poor asthma control, and missed
school days (Fig. 2). Compared to asthmatic children with-
out rhinitis, those with both asthma and rhinitis were:
• 2.89-fold (95% CI 1.41–5.91) more likely to experience
frequent attacks of wheezing (P < 0.01).
• 3.44-fold (95% CI 1.19–9.94) more likely to experience
severe attacks of wheezing limiting speech (P = 0.02).
• 10.14-fold (95% CI 1.27–81.21) more likely to have fre-
quent unscheduled visits to their doctor because of
asthma (P = 0.03).
1184 children born into the cohort
1051 Observational Cohort
AGE 8
145 no data 906  questionnaire









133 allocated to Intervention Group
Figure 1 Participant flow.





Never breastfed 30/130 (23.1) 32/88 (36.4) 0.03
Current maternal
smoking
18/140 (12.9) 23/89 (25.8) 0.01
Wheeze ever 90/140 (64.3) 44/89 (49.4) 0.02
Current wheeze
(age 8 years)
68/140 (48.6) 12/89 (13.5) <0.001
Persistent wheeze 46/140 (32.9) 14/89 (15.7) 0.009
Current eczema
(age 8 years)
70/140 (50.0) 19/86 (22.1) <0.001
Eczema in the
first year
74/125 (59.2) 28/87 (32.2) <0.001
Interference with
daily activities
79/140 (56.4) 35/89 (39.3) 0.01
Spring/summer
pattern
90/140 (64.3) 41/89 (46.1) 0.009
Perennial 27/140 (19.3) 19/89 (21.3) 0.20
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• 9-fold (95% CI 1.11–72.83) more likely to miss school
because of their asthma (P = 0.04).
A trend that failed to reach statistical significance was
observed for nocturnal awakenings (OR 1.81, 95% CI 0.79–
4.12, P = 0.16).
Influence of treatment for rhinitis on the association of
rhinitis with asthma severity
We carried out an exploratory analysis to ascertain whether
treatment for rhinitis modifies the association of rhinitis
with asthma severity, using multivariate analyses adjusted
for the use of rhinitis medication (Table 2). Adjusting the
analysis for parentally reported use of antihistamines did
not remove the impact of rhinitis or modify the magnitude
of the risk associated with any of the markers of asthma
severity. In contrast, reported use of intranasal corticoster-
oids (INCS) resulted in a numerically small, but consistent
reduction in the risk of frequent wheeze attacks, wheeze
limiting speech, frequent GP visits and school days missed,
rendering these associations between rhinitis and asthma
severity nonsignificant. We observed similar reductions in
risks after adjusting the analysis for the use of ICS
(Table 2), whilst adjustment for both INCS and ICS
appeared to further minimize the impact of rhinitis on
asthma severity (Table S5).
Discussion
Key findings
Our population-based study demonstrated that amongst chil-
dren with asthma, the presence of rhinitis has significant
adverse effect on asthma severity. Amongst asthmatic chil-
dren, contemporaneous rhinitis was associated with more fre-
quent wheeze attacks (2.4-fold increase in risk), more severe
attacks of wheezing associated with speech limitations (3.4-
fold increase in risk), more frequent visits to the family doc-
tor (9.5-fold increase in risk) and greater school absenteeism
because of asthma (nine-fold increase in risk). Whereas
adjusting for the use of antihistamines did not change these
associations, adjusting for the use of INCS resulted in small,
but consistent reductions in risk, rendering the associations
between rhinitis and markers of asthma severity nonsignifi-
cant.
We observed differences in the associated risk and severity
between allergic and nonallergic rhinitis. Having never been
breastfed and being exposed to maternal smoking were
stronger associates of nonallergic than allergic rhinitis,
whereas current wheeze and eczema were significantly stron-


















Figure 2 Rhinitis and markers of asthma severity amongst 159
children with asthma.




n (%) OR 95% CI P-value
≥4 wheezing attacks 15/75 (20.0) 34/81 (41.9) 2.89 1.41–5.91 <0.01
Adjusted for antihistamines 2.93 1.42–6.03 <0.01
Adjusted for INCS 2.23 0.78–6.38 0.13
Adjusted for ICS 1.61 0.59–4.37 0.35
Wheeze limiting speech 5/75 (6.7) 16/81 (19.8) 3.44 1.19–9.94 0.02
Adjusted for antihistamines 3.62 1.25–10.51 0.02
Adjusted for INCS 3.19 0.79–12.89 0.10
Adjusted for ICS 2.13 0.64–7.05 0.22
≥4 visits to GP for asthma 1/75 (1.3) 10/83 (12.1) 10.14 1.27–81.21 0.03
Adjusted for antihistamines 10.35 1.28–83.34 0.03
Adjusted for INCS 7.13 0.83–61.17 0.07
Adjusted for ICS 7.68 0.89–6.17 0.06
≥6 school days missed 1/75 (1.3) 9/83 (10.8) 9.00 1.11–72.83 0.04
Adjusted for antihistamines 8.98 1.23–81.00 0.03
Adjusted for INCS 8.16 0.96–69.21 0.054
Adjusted for ICS 8.03 0.93–9.67 0.06
Allergy 69 (2014) 1515–1521 © 2014 The Authors. Allergy Published by John Wiley & Sons Ltd.1518
Childhood rhinitis and asthma severity Deliu et al.
Limitations
We relied on parental reporting of child’s symptoms and
acknowledge potential limitations of this approach (19). We
collected data on medication prescribed by primary care
physicians; this, however, does not confirm that the treat-
ments were taken by children. We were unable to obtain
data on all outcomes (including answers to all questions,
skin tests, lung function, AHR and FeNO) for all children;
however, we found no significant differences in demo-
graphic characteristics between children with and without
these data, suggesting that it is unlikely that this has influ-
enced the results (not presented, available on request). We
acknowledge that our definition of allergic rhinitis is an epi-
demiological one and that demonstration of the cause/effect
relationship between exposure to sensitizing allergen and
symptom would be preferable; however, such investigations
are beyond the remit of the present study. Finally, although
we carried out the analyses amongst children participating
in a longitudinal birth cohort study, due to cross-sectional
nature of these data, the results should be interpreted with
caution.
One strength of our study is the large sample of children,
representative of and generalizable to the general population,
with an excellent retention and high follow-up rate.
Interpretation
Prevalence, risk factors and characteristics
Our results confirm that rhinitis is common in school-age
children and that it frequently coexists with asthma (20, 21).
There was a strong association between rhinitis with current
and persistent, but not transient-early wheezing, suggesting
that different wheezing phenotypes may arise through differ-
ent mechanisms (19, 22). The results appear intuitively cor-
rect, with maternal smoking and the absence of breastfeeding
being stronger associates of nonallergic, and wheeze and
eczema of allergic rhinitis. These data suggest that there may
be different phenotypes of rhinitis during childhood,
with both shared and unique developmental pathways (23).
Longitudinal studies may help identification of such pheno-
types.
We found that children with allergic rhinitis had more
severe symptoms than those with nonallergic rhinitis. Simi-
larly, a significant (but underestimated) burden of allergic
rhinitis has been reported previously in a large-scale survey
in the USA (24) and amongst children with asthma from
Turkey (25).
Allergic rhinitis has been shown to increase FeNO, sug-
gesting increased lower airway inflammation (26, 27). In con-
trast to these studies, amongst atopic children in our study,
there was no association between FeNO and rhinitis. We
observed no differences in lung function between children
with and without rhinitis. However, in agreement with the
previous study by Koh et al., (28) we demonstrated higher
airway reactivity amongst children with rhinitis, even after
adjusting for the presence of asthma. Similarly, data from
cross-sectional (29) and population-based studies (30, 31) in
adults have suggested a strong association between allergic
rhinitis and lower airway dysfunction.
Rhinitis and asthma severity
In a recent important cross-sectional study amongst children
with asthma recruited from the hospital asthma clinic, the
presence of allergic rhinitis had significant adverse effect on
asthma control, even when asthma was considered ade-
quately controlled (9). We have extended these observations
to the unselected population of children with asthma and to
a number of other important markers of asthma severity
(including frequency and severity of wheeze attacks, unsched-
uled use of medical care and school absenteeism). Of particu-
lar note is our finding that children with asthma and rhinitis
have ninefold increase in the risk of missing school compared
to children with asthma only.
In both ours and the study by de Groot et al. (9), treat-
ment with INCS appeared to modify the association between
rhinitis and asthma severity. The observed reduction in risk
was not due to missing observations. This is consistent with
findings in a retrospective cohort of older children and
adults, which showed that patients who were treated for
allergic rhinitis were significantly less likely to visit emergency
departments or be hospitalized than those who were not
treated (32). However, this study did not differentiate
between antihistamines and INCS. One could argue that
children with asthma and rhinitis who receive appropriate
rhinitis treatment with INCS may also be prescribed better
asthma treatment, such as ICS. However, the apparent effect
of INCS on asthma severity in our study remained mostly
unchanged when we adjusted the analysis for the use of ICS,
suggesting that it is unlikely that the observed reduction in
asthma severity amongst children using INCS is confounded
by better treatment for asthma. These findings suggests (but
do not prove) that amongst children with asthma and rhini-
tis, appropriate treatment of rhinitis with INCS may improve
asthma control. The definitive answer can only be obtained
in appropriately designed randomized controlled trials; how-
ever, there are as yet no such long-term trials in children
(33). A recent 4-week study amongst children with mild/mod-
erate asthma and intermittent allergic rhinitis has shown that
INCS may improve exercise-induced bronchospasm (34). In
contrast, a double-blind randomized crossover trial amongst
adults with asthma and persistent allergic rhinitis did not
demonstrate any steroid-sparing effect of adding INCS to
low-dose ICS on lower airway outcomes (35). Recent meta-
analysis of 18 studies assessing the effect of INCS on asthma
outcomes in patients with AR and comorbid asthma
concluded that INCS may improve some lower airway
outcomes, but that further studies are needed to confirm
the role of INCS sprays as therapy for asthma outcomes
(33).
In conclusion, we observed differences in risk factors and
severity between allergic and nonallergic rhinitis amongst
school-age children. In children with asthma, the presence of
rhinitis had adverse impact on asthma severity. Adjustment
for the use of INCS resulted in a small, but consistent reduc-
tion in the risk.
Allergy 69 (2014) 1515–1521 © 2014 The Authors. Allergy Published by John Wiley & Sons Ltd. 1519
Deliu et al. Childhood rhinitis and asthma severity
Acknowledgments
We would like to thank the children and their parents for
their continued support and enthusiasm. We greatly appreci-
ate the commitment they have given to the project. We
would also like to acknowledge the hard work and dedication
of the study team (postdoctoral scientists, research fellows,
nurses, physiologists, technicians and clerical staff), and we
are grateful to Dr Lesley Lowe for her contribution to the
collection of lung function data.
Author contributions
AC and AS conceived the idea for this study. AC is a princi-
pal investigator of MAAS. MD and DB analysed the data.
All authors interpreted the data. CSM and GK contributed
to data collection. MD and AC wrote the manuscript with
input from all authors.
Funding
MAAS is supported by MRC Grants G0601361 and MR/
K002449/1, JP Moulton Charitable Foundation and National
Institute for Health Research Clinical Research Facility at
University Hospital of South Manchester NHS Foundation
Trust.
Conflicts of interest
A. Custovic served as a consultant for Circassia. He received
speaker fees from GlaxoSmithKline, Thermo Fisher Scientific,
Airsonet, Novartis, MSD and ALK. He received research
grants from the UK Medical Research Council, JP Moulton
Charitable Foundation and National Institute of Health
Research. Other authors declare no conflict of interest in
relation to this article.
Supporting Information
Additional Supporting Information may be found in the
online version of this article:
Figure S1. (A) Prevalence of current rhinitis, asthma, and
eczema in the study population; and (B) Proportional Venn
diagram showing the overlap of co-morbid current rhinitis,
asthma and eczema.
Table S1. Risk factors for rhinitis (univariate analysis).
Table S2. Association of rhinitis with asthma, current
wheeze and childhood wheeze phenotypes.
Table S3. Lung function (sRaw, FEV1 and FEV1/FVC),
airway hyper-reactivity (methacholine DRS-MDRS) and
FeNO at age 8 years in children with and without rhinitis
(analysis adjusted for asthma).
Table S4. Lung function (sRaw, FEV1 and FEV1/FVC),
airway hyper-reactivity (methacholine DRS) and FeNO at
age 8 years amongst asthmatic children with and without rhi-
nitis.
Table S5. Rhinitis and markers of asthma severity, among
asthmatic children, after adjustment for the use of inhaled
(ICS) and intranasal (INCS) corticosteroid.
References
1. Roberts G, Xatzipsalti M, Borrego LM,
Custovic A, Halken S, Hellings PW et al.
Paediatric rhinitis: position paper of the
European Academy of Allergy and Clinical
Immunology. Allergy 2013;68:1102–1116.
2. Marinho S, Simpson A, Soderstrom L,
Woodcock A, Ahlstedt S, Custovic A. Quan-
tification of atopy and the probability of rhi-
nitis in preschool children: a population-
based birth cohort study. Allergy
2007;62:1379–1386.
3. Marinho S, Simpson A, Lowe L, Kissen P,
Murray C, Custovic A. Rhinoconjunctivitis
in 5-year-old children: a population-based
birth cohort study. Allergy 2007;62:385–393.
4. Morais-Almeida M, Santos N, Pereira AM,
Branco-Ferreira M, Nunes C, Bousquet J
et al. Prevalence and classification of rhinitis
in preschool children in Portugal: a nation-
wide study. Allergy 2013;68:1278–1288.
5. Guerra S, Sherrill DL, Martinez FD, Barbee
RA. Rhinitis as an independent risk factor
for adult-onset asthma. J Allergy Clin Immu-
nol 2002;109:419–425.
6. Ek A, Middelveld RJ, Bertilsson H, Bjerg A,
Ekerljung L, Malinovschi A et al. Chronic
rhinosinusitis in asthma is a negative predic-
tor of quality of life: results from the Swed-
ish GA(2)LEN survey. Allergy
2013;68:1314–1321.
7. Custovic A, Johnston SL, Pavord I, Gaga
M, Fabbri L, Bel EH et al. EAACI
position statement on asthma exacerbations
and severe asthma. Allergy 2013;68:1520–
1531.
8. Lasmar LM, Camargos PA, Ordones AB,
Gaspar GR, Campos EG, Ribeiro GA.
Prevalence of allergic rhinitis and its impact
on the use of emergency care services in a
group of children and adolescents with mod-
erate to severe persistent asthma. J Pediatr
2007;83:555–561.
9. de Groot EP, Nijkamp A, Duiverman EJ,
Brand PL. Allergic rhinitis is associated with
poor asthma control in children with
asthma. Thorax 2012;67:582–587.
10. Simpson BM, Custovic A, Simpson A, Hal-
lam CL, Walsh D, Marolia H et al. NAC
Manchester Asthma and Allergy Study
(NACMAAS): risk factors for asthma and
allergic disorders in adults. Clin Exp Allergy
2001;31:391–399.
11. Asher MI, Keil U, Anderson HR, Beasley
R, Crane J, Martinez F et al. International
Study of Asthma and Allergies in Childhood
(ISAAC): rationale and methods. Eur Respir
J 1995;8:483–491.
12. Lowe L, Murray CS, Custovic A, Simpson
BM, Kissen PM, Woodcock A et al. Specific
airway resistance in 3-year-old children: a
prospective cohort study. Lancet
2002;359:1904–1908.
13. Stanojevic S, Wade A, Cole TJ, Lum S, Cus-
tovic A, Silverman M et al. Spirometry cen-
tile charts for young Caucasian children: the
Asthma UK Collaborative Initiative. Am J
Respir Crit Care Med 2009;180:547–552.
14. Crapo RO, Casaburi R, Coates AL, Enright
PL, Hankinson JL, Irvin CG et al. Guide-
lines for methacholine and exercise challenge
testing-1999. This official statement of the
American Thoracic Society was adopted by
the ATS Board of Directors, July 1999. Am
J Respir Crit Care Med 2000;161:309–329.
15. Beydon N, Davis SD, Lombardi E, Allen
JL, Arets HG, Aurora P et al. An official
American Thoracic Society/European
Respiratory Society statement: pulmonary
Allergy 69 (2014) 1515–1521 © 2014 The Authors. Allergy Published by John Wiley & Sons Ltd.1520
Childhood rhinitis and asthma severity Deliu et al.
function testing in preschool children. Am
J Respir Crit Care Med 2007;175:1304–1345.
16. American Thoracic Society, European Respi-
ratory Society. ATS/ERS recommendations
for standardized procedures for the online
and offline measurement of exhaled lower
respiratory nitric oxide and nasal nitric
oxide, 2005. Am J Respir Crit Care Med
2005;171:912–930.
17. Lowe LA, Simpson A, Woodcock A, Morris
J, Murray CS, Custovic A et al. Wheeze
phenotypes and lung function in preschool
children. Am J Respir Crit Care Med
2005;171:231–237.
18. Woodcock A, Lowe LA, Murray CS, Simp-
son BM, Pipis SD, Kissen P et al. Early life
environmental control: effect on symptoms,
sensitization, and lung function at age
3 years. Am J Respir Crit Care Med
2004;170:433–439.
19. Belgrave DC, Simpson A, Semic-Jusufagic
A, Murray CS, Buchan I, Pickles A et al.
Joint modeling of parentally reported and
physician-confirmed wheeze identifies chil-
dren with persistent troublesome wheezing.
J Allergy Clin Immunol 2013;132:575–583.
20. Peroni DG, Piacentini GL, Alfonsi L, Zer-
man L, Di Blasi P, Visona G et al. Rhinitis
in pre-school children: prevalence, associa-
tion with allergic diseases and risk factors.
Clin Exp Allergy 2003;33:1349–1354.
21. Schmitz R, Atzpodien K, Schlaud M. Preva-
lence and risk factors of atopic diseases in
German children and adolescents. Pediatr
Allergy Immunol 2012;23:716–723.
22. Belgrave DC, Custovic A, Simpson A. Char-
acterizing wheeze phenotypes to identify
endotypes of childhood asthma, and the
implications for future management. Expert
Rev Clin Immunol 2013;9:921–936.
23. Westman M, Kull I, Lind T, Melen E,
Stj€arne P, Toskala E et al. The link between
parental allergy and offspring allergic and
nonallergic rhinitis. Allergy 2013;68:1571–
1578.
24. Meltzer EO, Blaiss MS, Derebery MJ, Mahr
TA, Gordon BR, Sheth KK et al. Burden of
allergic rhinitis: results from the Pediatric
Allergies in America survey. J Allergy Clin
Immunol 2009;124(Suppl. 3):S43–S70.
25. Kocabas CN, Civelek E, Sackesen C, Orhan
F, Tuncer A, Adalioglu G et al. Burden of
rhinitis in children with asthma. Pediatr Pul-
monol 2005;40:235–240.
26. Jouaville LF, Annesi-Maesano I, Nguyen
LT, Bocage AS, Bedu M, Caillaud D. Inter-
relationships among asthma, atopy, rhinitis
and exhaled nitric oxide in a population-
based sample of children. Clin Exp Allergy
2003;33:1506–1511.
27. Zhao Z, Huang C, Zhang X, Xu F, Kan H,
Song W et al. Fractional exhaled nitric oxide
in Chinese children with asthma and aller-
gies–a two-city study. Respir Med
2013;107:161–171.
28. Koh YY, Lee MH, Kim CK, Min YG, Kim
YK, Min KU et al. A familial predisposition
in bronchial hyperresponsiveness among
patients with allergic rhinitis. J Allergy Clin
Immunol 1998;102:921–926.
29. Leynaert B, Bousquet J, Neukirch C, Liard
R, Neukirch F. Perennial rhinitis: an inde-
pendent risk factor for asthma in nonatopic
subjects: results from the European Commu-
nity Respiratory Health Survey. J Allergy
Clin Immunol 1999;104:301–304.
30. Shaaban R, Zureik M, Soussan D, Neukirch
C, Heinrich J, Sunyer J et al. Rhinitis and
onset of asthma: a longitudinal population-
based study. Lancet 2008;372:1049–1057.
31. Shaaban R, Zureik M, Soussan D, Anto
JM, Heinrich J, Janson C et al. Allergic rhi-
nitis and onset of bronchial hyperresponsive-
ness: a population-based study. Am J Respir
Crit Care Med 2007;176:659–666.
32. Crystal-Peters J, Neslusan C, Crown WH,
Torres A. Treating allergic rhinitis in
patients with comorbid asthma: the risk of
asthma-related hospitalizations and emer-
gency department visits. J Allergy Clin
Immunol 2002;109:57–62.
33. Lohia S, Schlosser RJ, Soler ZM. Impact of
intranasal corticosteroids on asthma out-
comes in allergic rhinitis: a meta-analysis.
Allergy 2013;68:569–579.
34. Kersten ET, van Leeuwen JC, Brand PL,
Duiverman EJ, de Jongh FH, Thio BJ et al.
Effect of an intranasal corticosteroid on exer-
cise induced bronchoconstriction in asthmatic
children. Pediatr Pulmonol 2012;47:27–35.
35. Nair A, Vaidyanathan S, Clearie K, Wil-
liamson P, Meldrum K, Lipworth BJ. Ste-
roid sparing effects of intranasal
corticosteroids in asthma and allergic rhini-
tis. Allergy 2010;65:359–367.
Allergy 69 (2014) 1515–1521 © 2014 The Authors. Allergy Published by John Wiley & Sons Ltd. 1521
Deliu et al. Childhood rhinitis and asthma severity
